Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis

참고문헌 (10)

1. Solovic I, "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement", Eur Respir J, 36, pp.1185~1206 (2010)
2. Maini R, "Inf liximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial: ATTRACT Study Group", Lancet, 354, pp.1932~1939 (1999)
3. Keane J, "Tuberculosis associated with inf liximab, a tumor necrosis factor alphaneutralizing agent", N Engl J Med, 345, pp.1098~1104 (2001)
4. Mohan VP, "Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology", Infect Immun, 69, pp.1847~1855 (2001)
5. Seong SS, "Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers", J Rheumatol, 34, pp.706~711 (2007)
6. Keun Bum Chung, "Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor", The Korean Journal of Internal Medicine, 28(2), pp.174~179 (2013), 대한내과학회[DOI]
7. Canet E, "Tuberculosis following kidney transplantation: clinical features and outcome: a French multicentre experience in the last 20 years", Nephrol Dial Transplant, 26, pp.3773~3778 (2011)
8. Holty JE, "Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data", Liver Transpl, 15, pp.894~906 (2009)
9. Jong Wook Yun, "Diagnosis and Treatment of Latent Tuberculosis Infection in ArthritisPatients Treated with Tumor Necrosis Factor Antagonists in Korea", Journal of Korean Medical Science, 22(5), pp.779~783 (2007), 대한의학회
10. 허지안, "류마티스관절염 환자에서 잠복결핵 진단을 위한 투베르쿨린 검사와 T-SPOT.TB 사이의 일치율에 관한 연구", 대한류마티스학회지, 13(4), pp.285~290 (2006), 대한류마티스학회

관련 논문AI추천